FDA: Companies Developing Breast Cancer Drugs Should Also Enroll Men
Chances are good that if you hear the term
Related Articles
Industry supports FDA’s draft guidance on weight management drugs, suggests some refinements | RAPS
The pharmaceutical industry generally supports draft guidance from the US Food and Drug Administration (FDA) on the development of drugs and biologics for weight reduction…
FDA makes flu vaccine recommendations after canceled VRBPAC, closed-door meeting | RAPS
After canceling a routine meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to review the composition of the 2025-2026 influenza vaccine, the…
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients
This cohort study assesses the risk of development of type 2 diabetes in pediatric patients aged 10 to 19 years after receiving a COVID-19 diagnosis…
Literacy Statistics 2022-2023
Literacy Data and its impact on the Nation • Illiteracy has become such a serious problem in our country that 130 million adults are now…
DonorsChoose: Support a classroom. Build a future.
DonorsChoose connects teachers in high-need communities with donors who want to help.
The Elephantine Memories of Food-Caching Birds
Some animals can remember where they’ve buried hundreds of thousands of seeds. Why can’t we remember where we’ve put our eyeglasses?
Coca-Cola issues safety recall of soft drinks in Europe over chemical chlorate concerns
Coca-Cola has recalled some of its soft drinks in Europe after higher-than-normal levels of a chemical called chlorate were detected in bottles and cans at…
SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells
Scientific Reports – SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells
Gut–brain axis and neuropsychiatric health: recent advances
Scientific Reports – The gut–brain axis, a bidirectional communication pathway, permits the central nervous system (CNS) to exert influence over gastrointestinal function in response to…
Woman, 33, called “hypochondriac” by dr diagnosed with colorectal cancer
The 33-year-old told Newsweek that she wasn’t taken seriously, despite suffering from one major warning sign.